Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants.
Recent experimental and epidemiological studies have suggested that osteoprotegerin, a key regulator in bone metabolism, may be involved in vascular calcification and atherosclerosis. Our aim was to reliably quantify the associations of osteoprotegerin concentration and incidence of first-ever cardi...
Main Authors: | Lena Tschiderer, Johann Willeit, Georg Schett, Stefan Kiechl, Peter Willeit |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5570489?pdf=render |
Similar Items
-
STROKE-CARD care to prevent cardiovascular events and improve quality of life after acute ischaemic stroke or TIA: A randomised clinical trial
by: Peter Willeit, et al.
Published: (2020-08-01) -
Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack –study protocol
by: Thomas Toell, et al.
Published: (2018-11-01) -
Phenotypical variability of post-partum reversible cerebral vasoconstriction syndrome
by: Benjamin Matosevic, et al.
Published: (2010-09-01) -
Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01) -
Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.
by: Peter Willeit, et al.
Published: (2014-01-01)